Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Growth Hormone / IGF-1 & Testosterone

The Somatotropic Axis and Its Interplay with Androgens

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
GH restricted; off-label/anti-aging use is illegal in the US for that indication
WADA
Prohibited (S2 Peptide Hormones / Growth Factors)

Reference only. Not medical advice.

What can go wrong

GH sold for anti-aging or athletic use is illegal in the US and frequently counterfeit. Stacking GH/IGF-1 with testosterone amplifies fluid retention, joint pain, glucose intolerance, and cardiovascular strain. None of this is a sanctioned therapy for low testosterone.

This is something to take to a clinician. The Atlas can tell you what is known about growth hormone / igf-1 & testosterone in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Growth hormone and its downstream mediator IGF-1 interact with the testosterone axis in both directions: androgens support GH secretion and IGF-1 generation, while GH/IGF-1 may enhance some androgen-dependent tissue effects. The two are frequently stacked in performance and 'anti-aging' settings, but distributing GH for anti-aging or athletic use is illegal in the United States, and the combination magnifies anabolic side effects.

Two anabolic axes that amplify each other, and that the gray market loves to stack.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Reported physique/recovery stacking with testosterone (off-label, often illicit)
  • Evaluation of combined hypopituitarism where both axes fail

Combinations named above are how people use these compounds together, under names the community gave them. The combinations themselves have not been studied. Evidence for one compound is not evidence for a pair.

How it is supposed to work

Sex steroids influence the amplitude of GH pulses and the liver's IGF-1 output; testosterone administration can raise IGF-1. GH and IGF-1 in turn promote nitrogen retention, lipolysis, and tissue growth that overlap with androgenic anabolism. In true pituitary disease both axes can be deficient together and may be replaced together under specialist care.

Safety in detail

This intervention involves significant physiological effects and requires evaluation and monitoring by a qualified physician. Self-administration without medical oversight carries documented health risks, and non-prescription distribution of growth hormone is illegal in the United States.

Replacement is not the same as a cycle

Physiologic replacement of GH applies only to documented adult GH deficiency under endocrinology care. Supraphysiologic GH/IGF-1 stacked with testosterone for physique or performance is a different practice entirely, associated with insulin resistance, fluid retention, carpal tunnel, acromegalic changes with chronic use, and theoretical concerns about promoting growth of existing tumors.

What it does to fertility

GH/IGF-1 are not a recognized fertility therapy in men; any exogenous testosterone stacked alongside still suppresses the HPG axis and impairs spermatogenesis. GH has been studied as an adjunct in some assisted-reproduction protocols, but evidence in men is limited.

What has to be monitored

The bloodwork this needs, and the reason it belongs with a clinician rather than a website.

  • IGF-1 level
  • Fasting glucose / HbA1c
  • Blood pressure and fluid status
  • Testosterone and standard TRT labs if co-administered

What people get wrong

  • Often saidGH plus testosterone safely reverses aging

    ActuallyNo. Anti-aging GH use is unproven and illegal to distribute for that purpose in the US, and the combination raises metabolic and cardiovascular risk.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Mediator
IGF-1 (mostly hepatic, GH-driven)
Direction
Bidirectional; androgens support GH pulses
Legal status (GH)
No legal anti-aging/athletic distribution in the US
WADA
GH and IGF-1 are prohibited

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Growth Hormone / IGF-1 & Testosterone. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.